Methods of determining disease activity in SLE patients by corre

Details Methods of determining disease activity in SLE patients by corre Methods of determining disease activity in SLE patients by corre

1997-11-07

2000-09-12

Gambel, Phillip

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving antigen-antibody binding, specific binding protein...

436501, 436506, 436536, G01N 3353, G01N 33536

Patent

active

061176427

ABSTRACT:
The present invention provides diagnostic methods for determining the severity of disease or disease activity in patients suffering from autoimmune, inflammatory, malignant, vascular, or viral diseases, which involves measuring the level of CD40 ligand (CD40L) in the patient's serum or other body fluid.

REFERENCES:
patent: 5292636 (1994-03-01), Kung et al.
Graf et al. Eur. J. Immunol. 25: 1749-1754 (1995).
Koshy et al. J. Clin Invest. 98: 826-837 (1996).
Desai-Mehta et al. Arthritis & Rheumatism 38 (9 Suppl.) p. S314 (1995).
Koshy et al. et al. Arthritis & Rheumatism 38 (9 Suppl) p. S156 (1995).
Vakkalanka et al., Arthritis & Rheumatism, 39(9):S35 abstract 52, 1996.
MacDonald et al., Arthritis & Rheumatism, 39(9):s159, abstract 793, 1996.

Affiliated with

Also associated with

Rating

Methods of determining disease activity in SLE patients by corre does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of determining disease activity in SLE patients by corre, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of determining disease activity in SLE patients by corre will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-94499